Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Why All the Fuss about Oxidative Phosphorylation (OXPHOS)?
Yibin Xu, Ding Xue, Armand Bankhead, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 23, pp. 14276-14307
Open Access | Times Cited: 110

Showing 1-25 of 110 citing articles:

Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials
Timothy A. Yap, Naval Daver, Mikhila Mahendra, et al.
Nature Medicine (2023) Vol. 29, Iss. 1, pp. 115-126
Open Access | Times Cited: 191
Metabolic Intervention Liposome Boosted Lung Cancer Radio‐Immunotherapy via Hypoxia Amelioration and PD‐L1 Restraint
Saijun Wang, Zaigang Zhou, Rui Hu, et al.
Advanced Science (2023) Vol. 10, Iss. 18
Open Access | Times Cited: 46
Cancer resistance and metastasis are maintained through oxidative phosphorylation
Cemile Uslu, Eda Kapan, Alex Lyakhovich
Cancer Letters (2024) Vol. 587, pp. 216705-216705
Closed Access | Times Cited: 17
Melatonin drives apoptosis in head and neck cancer by increasing mitochondrial ROS generated via reverse electron transport
Javier Florido, Laura Martinez‐Ruiz, César Rodríguez-Santana, et al.
Journal of Pineal Research (2022) Vol. 73, Iss. 3
Open Access | Times Cited: 54
Crosstalk between oxidative phosphorylation and immune escape in cancer: a new concept of therapeutic targets selection
Xutong Qiu, Yi Li, Zhuoyuan Zhang
Cellular Oncology (2023) Vol. 46, Iss. 4, pp. 847-865
Closed Access | Times Cited: 27
OXPHOS-targeting drugs in oncology: new perspectives
Balaraman Kalyanaraman, Gang Cheng, Micaël Hardy, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 10, pp. 939-952
Open Access | Times Cited: 24
Targeting mitochondrial oxidative phosphorylation: lessons, advantages, and opportunities
Nicole Machado, Lisa C. Heather, Adrian L. Harris, et al.
British Journal of Cancer (2023) Vol. 129, Iss. 6, pp. 897-899
Open Access | Times Cited: 23
Reductive stress in cancer: coming out of the shadows
Maolin Ge, Thales Papagiannakopoulos, Liron Bar‐Peled
Trends in cancer (2023) Vol. 10, Iss. 2, pp. 103-112
Closed Access | Times Cited: 23
Mitochondrial Dysfunction and Metabolic Reprogramming in Obesity and Asthma
Paige Hartsoe, Fernando Holguín, Hong Wei Chu
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2944-2944
Open Access | Times Cited: 8
Exploiting metabolic vulnerability in glioblastoma using a brain-penetrant drug with a safe profile
Audrey Burban, Cloé Tessier, Mathieu Larroquette, et al.
EMBO Molecular Medicine (2025)
Open Access | Times Cited: 1
Carrier Free O2‐Economizer for Photodynamic Therapy Against Hypoxic Tumor by Inhibiting Cell Respiration
Jiaqi Huang, Linping Zhao, Xiang Zhou, et al.
Small (2022) Vol. 18, Iss. 15
Closed Access | Times Cited: 33
Transcriptome profiling reveals that VNPP433‐3β, the lead next‐generation galeterone analog inhibits prostate cancer stem cells by downregulating epithelial–mesenchymal transition and stem cell markers
Elizabeth Thomas, Retheesh S. Thankan, Puranik Purushottamachar, et al.
Molecular Carcinogenesis (2022) Vol. 61, Iss. 7, pp. 643-654
Open Access | Times Cited: 29
Targeting Mitochondria with ClpP Agonists as a Novel Therapeutic Opportunity in Breast Cancer
Rohan Wedam, Yoshimi Endo Greer, David Wisniewski, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 1936-1936
Open Access | Times Cited: 21
OXPHOS inhibitors, metabolism and targeted therapies in cancer
Octavia Cadassou, Lars Petter Jordheim
Biochemical Pharmacology (2023) Vol. 211, pp. 115531-115531
Open Access | Times Cited: 19
Sequence-based prediction of the intrinsic solubility of peptides containing non-natural amino acids
Marc Oeller, Ryan Kang, Hannah L. Bolt, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 17
Mitochondrial signaling pathways and their role in cancer drug resistance
Ashwani Sharma, Tarun Virmani, Girish Kumar, et al.
Cellular Signalling (2024) Vol. 122, pp. 111329-111329
Closed Access | Times Cited: 7
The Warburg Effect Reinterpreted 100 yr on: A First-Principles Stoichiometric Analysis and Interpretation from the Perspective of ATP Metabolism in Cancer Cells
Sunil Nath, Rudi Balling
Function (2024) Vol. 5, Iss. 3
Open Access | Times Cited: 6
Cryptotanshinone suppresses ovarian cancer via simultaneous inhibition of glycolysis and oxidative phosphorylation
Tong Wang, Mengmeng Zhang, Muhammad Tahir Khan, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 115956-115956
Open Access | Times Cited: 13
Mitochondrial inhibitors: a new horizon in breast cancer therapy
Yalan Yan, Sijie Li, Lanqian Su, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Pan-cancer analysis of Arp2/3 complex subunits: focusing on ARPC1A’s role and validating the ARPC1A/c-Myc axis in non-small cell lung cancer
Chenkang Zhou, Y. Q. Chen, Shuhui Chen, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
DNA replication stress underpins the vulnerability to oxidative phosphorylation inhibition in colorectal cancer
Xiao Hong Zhao, Man Man Han, Qian Yan, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Multi-Water Bridges Enable Design of BET BD1-Selective Inhibitors for Pancreatic Cancer Therapy
Xuetao Chen, Wenjing Kang, Tingting Wu, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Low dose Taxol causes mitochondrial dysfunction in actively respiring cancer cells
Rozhin Penjweini, Katie A. Link, Shureed Qazi, et al.
Journal of Biological Chemistry (2025), pp. 108450-108450
Open Access
High-Resolution Tracking of Aging-Related Small Molecules: Bridging Pollutant Exposure, Brain Aging Mechanisms, and Detection Innovations
Keying Yu, Soo In Yang, H.-P. Song, et al.
Biosensors (2025) Vol. 15, Iss. 4, pp. 242-242
Open Access
Characterization of TR‐107, a novel chemical activator of the human mitochondrial protease ClpP
Emily M.J. Fennell, Lucas J. Aponte‐Collazo, Joshua D. Wynn, et al.
Pharmacology Research & Perspectives (2022) Vol. 10, Iss. 4
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top